News 2021/01/27 Institute develops double antibody against COVID-19 Researchers at the Institute for Research in Biomedicine have managed to combine two antibodies against COVID-19 into a single entity. This doubl...
Aktuell 2021/01/27 Institut entwickelt doppelten Antikörper gegen COVID-19 Forschende des Instituts für Forschung in der Biomedizin haben zwei Antikörper gegen COVID-19 zu einem verschmolzen. Dieser doppelte Antikörper s...
Aktuell 2020/04/15 B. Braun baut den Produktionsstandort Schweiz für Desinfektionsmittel aus Der Medizinproduktehersteller B. Braun verdoppelt in Sempach seine Kapazitäten zur Produktion von Desinfektionsmittel. Insgesamt will er 70 Milli...
News 2021/12/06 Roche tests able to detect Omicron The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of the disease. These te...
News 2021/01/20 Swiss PharmaCan successfully tests anti-COVID drug Swiss PharmaCan and Australia-based MGC Pharma have successfully concluded phase II clinical testing for their COVID-19 therapeutic candidate, Ar...
News 2020/03/30 Hand sanitizer: a Swiss invention that has been saving lives for decades The most sought after product in the midst of the COVID-19 pandemic is a Swiss invention. The hydro-alcoholic gel was formulated in the 1970s by ...
News 2020/09/07 Roche testing for coronavirus and flu simultaneously The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that simultaneously tests...
News 2020/08/21 Researchers develop novel approach against the coronavirus The Swiss National Science Foundation is funding a novel approach for a coronavirus vaccine. This approach developed by virologist Cornel Fraefel...
News 2020/08/25 Bloom Diagnostics raises capital for COVID-19 antibody tests The smart diagnosis system developed by Bloom Diagnostics is set to make COVID-19 antibody testing accessible to all. The test process takes just...
ニュース 2020/04/20 ビー・ブラウン、スイスでの製造を強化 製薬機器メーカーのビー・ブラウン社は、スイス・ルツェルン州ゼンパハの消毒剤生産拠点の2倍拡大計画を発表し、総費用7,000万スイスフランの投資を目指しています。ビー・ブラウン社CEOのRoman Kübler氏は、この生産拠点拡大計画はスイスに拠点を構え、貢献することへの明確な意思表示であ...
Success stories 2023/05/25 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
News 2020/10/07 Lonza to start manufacturing Moderna’s Covid-19 vaccine this December Lonza's new building dedicated to the manufacturing of Moderna's Covid-19 vaccine will be operational starting December 2020. 300 million doses w...
News 2020/09/16 Lonza set to manufacture coronavirus drug for Humanigen The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonz...